The potential health risks of weight-loss medications have been extensively discussed. Although it is mostly very helpful in preventing diabetes and obesity, there have been instances when it has been connected—albeit indirectly—to mental health issues. However, some noteworthy advantages of the weight loss medications were shown in a recent study based on data from US veterans with type 2 diabetes.
Originally designed to treat type 2 diabetes, medications including Ozempic, Wegovy, and Mounjaro have gained popularity for helping people lose weight, which has led to an expansion in their usage.
According to the study, these medications have been linked to decreased blood pressure, heart attacks, strokes, and heart failure. In actuality, it has demonstrated a notable reduction in disorders such as seizures, schizophrenia, and suicidal thoughts. This discovery may contradict the US doctor’s assertions regarding the connection between weight loss medications and mental health problems. According to the report, substance misuse involving alcohol, opioids, and cannabis has decreased as well.
Additionally, the study discovered a 12% decrease in Alzheimer’s disease, particularly among those who took the medication for 3.5 years. Along with fever and muscle soreness, the medication also decreased bacterial infections, liver cancer, and chronic renal problems.
More cases of nausea, stomach pain, inflammation, and ailments like diverticulitis and haemorrhoids were reported by participants.
Despite the fact that weight loss frequently reduces joint stress, these medications were unexpectedly connected to joint discomfort and arthritis.
Among the reported problems were kidney stones, headaches, low blood pressure, fainting, and sleep disturbances.
The study also saw a rise in pancreatic inflammation, which can be fatal.
Semaglutide, the active component of Ozempic and Wegovy, functions by imitating the hormone glucagon-like peptide-1 (GLP-1). Following a meal, the gut releases this hormone, which tells the brain to reduce hunger and causes you to feel fuller more quickly. Nevertheless, GLP-1 receptors can have a variety of impacts beyond merely suppressing hunger because they are found in all parts of the body, including the heart and immune system. The hormone that makes you feel full is triggered by weight reduction medications, and this also has a variety of effects on other body areas that have receptors.
Medically approved medications have two sides, just like anything else. Because fat around the throat can obstruct airways, losing excess weight helps treat disorders like sleep apnea. In addition to improving a number of medical disorders, lower inflammation can also inhibit the brain’s reward system, which lessens addictive behaviours like drinking and gambling.
The study contains limitations in spite of the encouraging results. There are gaps in our knowledge of how these medicines affect women or other populations because the majority of participants were white men. Anecdotal indications of increased fertility and “Ozempic kids” emphasize the need for more thorough studies.
Furthermore, because the study was observational, it is challenging to say whether the advantages were brought about by the medications directly or by other influences. The results are being confirmed by current clinical research, particularly in areas like Alzheimer’s prevention.
-NSH Digidesk
